Article
Development of a prognostic signature based on six immune related lncRNAs for hepatocellular carcinoma.
2020-03-09
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: Hepatocellular carcinoma (HCC) is one of the most common malignant tumor in the world which prognosis is poor. Therefore, a precise biomarker is needed to guide treatment and improve prognosis. More and more studies have shown that lncRNAs and immune response are closely related to the prognosis of hepatocellular carcinoma. The aim of this study was to establish...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 01b9dd2d-5325-586e-9cff-0e67310aa62a
- DOI
- 10.21203/rs.3.rs-16348/v1